Alliance Pharma agrees £132mn Sinclair deal

26 November 2015 - Deborah Wilkes

Archived

UK-based Alliance Pharma is set to boost its presence in dermatology by acquiring 27 healthcare products from Sinclair IS Pharma in a deal worth £132 million (US$199 million).

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: